Results 51 to 60 of about 11,689 (208)

Summary of solicited reactogenicity.

, 2018
Summary of solicited reactogenicity.
Myeisha Paskel (5925674), Brenda Larkin (736365), Buddy Creech (5925680), Harry Keyserling (68118), Barney S. Graham (194312), Edwin Anderson (5925677), David I. Bernstein (214403), Peter F. Wright (320340), Julie E. Ledgerwood (253787), Mary E. Enama (253785), Uzma Sarwar (736364), Abbie R. Bellamy (736359), Katherine V. Houser (240527), Galina V. Yamshchikov (725872), Robert T. Bailer (241545), Richard Koup (10461), Kanta Subbarao (65608), Paul Spearman (156002), Jeanine May (5925671)   +18 more
core   +1 more source

Immunogenicity and Reactogenicity of Coadministration of COVID-19 and Influenza Vaccines

JAMA Network Open, 2023
ImportanceCOVID-19 and seasonal influenza vaccines were previously given separately, although their coadministration is warranted for vaccination adherence. Limited data on their coadministration have been published.ObjectiveTo compare the reactogenicity and immunogenicity of COVID-19 and influenza vaccinations administered together with those of COVID-
Gonen, Tal, Barda, Noam, Asraf, Keren, Joseph, Gili, Weiss-Ottolenghi, Yael, Doolman, Ram, Kreiss, Yitshak, Lustig, Yaniv, Regev-Yochay, Gili   +8 more
openaire   +2 more sources

Study of Anaphylactogenic Properties of F(ab')2-Fragments of Heterologous Anti-Rabies Immunoglobulin

Проблемы особо опасных инфекций, 2009
Anaphylactogenic properties of heterologous anti-rabies immunoglobulin and its F(ab')2-fragments were tested in vivo. It was shown that F(ab')2-fragments of heterologous anti-rabies immunoglobulin did not possess anaphylactogenic properties.
S.V. Generalov, G.P. Lazarenko, R.A. Svintsov, I.M. Zhulidov, A.G. Selezneva, T.A. Mikheeva, L.N. Minaeva, M.V. Galkina, L.V. Savitskaya, A.K. Nikiforov, E.G. Abramova, Yu.V. Brandzishevskiy   +11 more
doaj   +1 more source

An open-label randomized clinical trial of prophylactic paracetamol coadministered with 7-valent pneumococcal conjugate vaccine and hexavalent diphtheria toxoid, tetanus toxoid, 3-component acellular pertussis, hepatitis B, inactivated poliovirus, and Haemophilus influenzae type b vaccine

, 2013
BACKGROUND: In two clinical trials, low-grade fever was observed more frequently after coadministration than after separate administration of two recommended routine pediatric vaccines.
Rose, Markus A., William C Gruber, Sherryl Baker, Christine Juergens, Beate Schmoele-Thoma, Gruber, William C., Stefan Zielen, Zielen, Stefan, Jürgens, Christine, Schmoele-Thoma, Beate, Baker, Sherryl, Markus A Rose   +11 more
core   +1 more source

Stacked bar charts of maximum local and systemic reactogenicity over all vaccinations.

, 2020
Local (A) and systemic (B) reactogenicity events. P values indicate differences between vaccine and placebo groups. Reactogenicity event grading color-code: red = life-threatening, orange = severe, pink = moderate, dark blue = mild, light blue = none.
Lynn Morris (7883), Chenchen Yu (345138), Nonhlanhla N. Mkhize (3094884), Vijay L. Mehra (8486019), Linda-Gail Bekker (60754), Fatima Laher (238017), Nicole Frahm (64219), Shannon Grant (5080577), Lawrence Corey (140058), Nicole Grunenberg (662181), Nicole L. Yates (7163783), Sanjay Phogat (3780025), Carlos A. DiazGranados (8486010), Marguerite Koutsoukos (296151), Carter Bentley (795220), Olivier Van Der Meeren (8486013), Kristen W. Cohen (8378880), David C. Montefiori (7392644), Zoe Moodie (211088), Kathryn Mngadi (795219), Brodie Daniels (4178137), Peter B. Gilbert (7431215), Michael N. Pensiero (8486016), Craig Innes (662182), Glenda E. Gray (8378892), Kevin Saunders (5166347), M. Juliana McElrath (8048912), Georgia D. Tomaras (7163792), Mary Allen (742378), Mookho Malahleha (5783144), James G. Kublin (8173401)   +30 more
core   +1 more source

Maximum Local Reactogenicity Summary for All Vaccinations.

, 2014
Maximum Local Reactogenicity Summary for All Vaccinations.
Julie E. Ledgerwood (253787), Ingelise J. Gordon (400269), Laura Novik (253779), Mary E. Enama (253785), Richard A. Koup (241544), Martha C. Nason (253782), LaSonji Holman (534213), Robert T. Bailer (241545), Mario Roederer (5259), John R. Mascola (229761), Barney S. Graham (194312), Gary J. Nabel (173301)   +11 more
core   +1 more source

Reactogenicity, safety and immunological efficacy of the live, pentavalent rotavirus vaccine in childhood immunization (results of the multicenter clinical trial)

Журнал микробиологии, эпидемиологии и иммунобиологии, 2020
Introduction. Rotavirus infection (RVI) is the most common cause of severe gastroenteritis in infants and young children worldwide: 600,000 children die annually; it accounts for approximately 3 million hospitalizations and 25 million physician visits ...
Irina V. Feldblium, Ksenya A. Subbotina, Olga A. Rychkova, Aleksander N. Mironov, Daria A. Volkova, Azamat O. Metov, Irina V. Sakaeva, Natalia V. Kupina, Mikhail S. Karbyshev, Nikita A. Nikita A. Mironov —, Yaroslava Yu. Kondratyeva   +10 more
doaj   +1 more source

Immunogenicity, safety, and reactogenicity of combined reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine administered as a booster vaccine dose in healthy Russian participants: a phase III, open-label study

Human Vaccines & Immunotherapeutics, 2021
As vaccine-induced immunity and protection following natural pertussis infection wane over time, adults and adolescents may develop pertussis and become transmitters to unprotected infants.
Asmik Asatryan, Nadia Meyer, Michael Scherbakov, Victor Romanenko, Irina Osipova, Anna Galustyan, Olga Shamsheva, Tatiana Latysheva, Tatyana Myasnikova, Nathalie Baudson, Monique Dodet, Stebin Xavier, Lauriane Harrington, Anastasia Kuznetsova, Laura Campora, Peter Van den Steen   +15 more
doaj   +1 more source

Enhanced passive safety surveillance of a trivalent and a quadrivalent influenza vaccine in Denmark and Finland during the 2018/2019 season

Human Vaccines & Immunotherapeutics, 2021
The European Medicines Agency requires Enhanced Passive Safety Surveillance (EPSS) for all seasonal influenza vaccines. Here, we report the EPSS results for the trivalent inactivated influenza vaccine (IIV3; Vaxigrip®) and the quadrivalent inactivated ...
Laurence Serradell, Sophie Wagué, Annick Moureau, Markku Nissilä, Anne-Laure Chabanon   +4 more
doaj   +1 more source

Tiny carriers, big impact: How Fusobacterium nucleatum extracellular vesicles drive oral diseases and beyond

Interdisciplinary Medicine, EarlyView.
This review explores how Fusobacterium nucleatum extracellular vesicles drive local oral diseases and distal pathologies via sophisticated cross‐compartment cross talk. It highlights the transformative potential of these “tiny carriers” as next‐generation molecular intermediaries for advanced health monitoring and innovative bio‐interventions by ...
Rongyang Ma, Jiahui Huang, Yitong Chen, Haoxuan Wang, Hang Zou, Wanghong Zhao, Zilong Deng   +6 more
wiley   +1 more source